SEPCELL at the EU-MSC2 Meeting | September 12-13 2017, Leiden, The Netherlands
The SEPCELL Consortium was invited to join the EU-MSC2 meeting in Leiden, The Netherlands. EU-MSC2 is a scientific meeting gathering EU funded consortia working on immune modulation using Mesenchymal Stromal Cells (EU-MSC2). Nine EU financed research consortia gathered at this event to further the knowledge on MSC research.
Dr. Olga de la Rosa, Scientific Director at TiGenix, presented the SEPCELL Consortium, the challenges faced and the progress on the trial.